Sumitomo Mitsui Trust Group’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Sell
29,724
-413
-1% -$5.85K ﹤0.01% 1049
2026
Q1
$486K Sell
30,137
-1,670
-5% -$43.7K ﹤0.01% 937
2025
Q4
$641K Sell
31,807
-3,035
-9% -$44.3K ﹤0.01% 907
2025
Q3
$301K Sell
34,842
-9,086
-21% -$65.1K ﹤0.01% 1012
2025
Q2
$139K Hold
43,928
﹤0.01% 1027
2025
Q1
$198K Sell
43,928
-7,711
-15% -$48.2K ﹤0.01% 1016
2024
Q4
$349K Sell
51,639
-2,664
-5% -$12.3K ﹤0.01% 983
2024
Q3
$177K Sell
54,303
-1,943
-3% -$10.7K ﹤0.01% 1044
2024
Q2
$363K Sell
56,246
-2,897
-5% -$22.1K ﹤0.01% 995
2024
Q1
$431K Sell
59,143
-7,564
-11% -$63.1K ﹤0.01% 1032
2023
Q4
$620K Hold
66,707
﹤0.01% 1025
2023
Q3
$647K Hold
66,707
﹤0.01% 1024
2023
Q2
$1.43M Buy
66,707
+741
+1% +$19.7K ﹤0.01% 963
2023
Q1
$1.85M Sell
65,966
-5,437
-8% -$163K ﹤0.01% 919
2022
Q4
$1.61M Sell
71,403
-2,780
-4% -$63.4K ﹤0.01% 960
2022
Q3
$1.77M Sell
74,183
-1,117
-1% -$36K ﹤0.01% 956
2022
Q2
$2.19M Sell
75,300
-137,351
-65% -$6.13M ﹤0.01% 937
2022
Q1
$19.8M Buy
212,651
+95,397
+81% +$8.29M 0.01% 733
2021
Q4
$11.2M Buy
117,254
+15,320
+15% +$2.1M 0.01% 763
2021
Q3
$18.2M Buy
101,934
+15,277
+18% +$3.4M 0.01% 728
2021
Q2
$25.5M Buy
86,657
+323
+0.4% +$95.6K 0.02% 694
2021
Q1
$23.2M Buy
86,334
+46,205
+115% +$14.1M 0.01% 695
2020
Q4
$9.27M Buy
+40,129
New +$10.8M 0.01% 781

Other funds holding BNR

Sumitomo Mitsui Trust Group's BNR Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Burning Rock Biotech (BNR) stake by 1.4% in Q2 2026, selling an estimated $5.85K and leaving 29,724 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Sumitomo Mitsui Trust Group first reported a position in BNR in Q4 2020 and has held it in 23 quarters since. The position peaked at $25.5M in Q2 2021. 3 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 29,724 shares of Burning Rock Biotech worth $249K as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 413 Burning Rock Biotech shares in Q2 2026, an estimated $5.85K.
  • Burning Rock Biotech made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #1049 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Burning Rock Biotech in Q4 2020 and has held it in 23 quarters since.
  • Sumitomo Mitsui Trust Group's Burning Rock Biotech position peaked at $25.5M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.